Encelimab Antibody
Encelimab, an anti-LAG3 monoclonal antibody, blocks LAG-3 binding to MHC class II, promoting T-cell activation and anti-tumor immunity. It demonstrates preclinical efficacy by reducing tumor burden in lymphoma models like A20 xenografts, both as monotherapy and with anti-PD-1, supporting cancer immunotherapy research.
Product Specifications
Target
LAG-3
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
5.48 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
144.57 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog